Purdue Pharma has filed a new reorganization plan that aims to deliver more than $7.4 billion in cash to creditors, subject to certain reserves, to compensate victims and abate the opioid crisis.

Purdue Pharma has filed a new bankruptcy plan as part of a $7.4 billion settlement to resolve thousands of lawsuits over the company’s alleged role in the opioid crisis, months after the Supreme ...

Purdue Pharma has filed a new bankruptcy plan that will distribute more than $7.4 billion to compensate opioid epidemic ...

Purdue Pharma filed a new bankruptcy plan on Tuesday, a major step toward finalizing a proposed opioid settlement of at least $7.4 billion after a setback in the U.S. Supreme Court last year.

Purdue Pharma submitted a new bankruptcy plan Tuesday, which will give its creditors more than $7.4 billion in cash—including up to $7 billion in payments from the billionaire Sackler family ...

Purdue Pharma asked a bankruptcy judge this week to consider the latest version of its plan to settle thousands of lawsuits over the toll of the powerful prescription painkiller OxyContin ...

Purdue Pharma on Wednesday filed a new bankruptcy reorganization plan to resolve mass lawsuits alleging that the OxyContin maker and its Sackler family owners contributed to the opioid crisis.

--(BUSINESS WIRE)--Purdue Pharma L.P. (“Purdue”) today filed a Chapter 11 Plan of Reorganization (the “Plan”) and related disclosure statement with the United States Bankruptcy Court for ...

Purdue Pharma asked a bankruptcy judge late Tuesday to consider the latest version of its plan to settle thousands of lawsuits over the toll of the powerful prescription painkiller OxyContin ...